Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Relationship between the Expression of CHK2 and p53 in Tumor Tissue and the Course of Papillary Thyroid Cancer in Patients with CHEK2 Germline Mutations.
Gąsior-Perczak D, Kowalik A, Kopczyński J, Macek P, Niemyska K, Walczyk A, Gruszczyński K, Siołek M, Dróżdż T, Kosowski M, Pałyga I, Przybycień P, Wabik O, Góźdź S, Kowalska A. Gąsior-Perczak D, et al. Cancers (Basel). 2024 Feb 17;16(4):815. doi: 10.3390/cancers16040815. Cancers (Basel). 2024. PMID: 38398207 Free PMC article.
Coexisting Germline CHEK2 and Somatic BRAFV600E Mutations in Papillary Thyroid Cancer and Their Association with Clinicopathological Features and Disease Course.
Gąsior-Perczak D, Kowalik A, Walczyk A, Siołek M, Gruszczyński K, Pałyga I, Mikina E, Trybek T, Kopczyński J, Mężyk R, Góźdź S, Kowalska A. Gąsior-Perczak D, et al. Cancers (Basel). 2019 Nov 7;11(11):1744. doi: 10.3390/cancers11111744. Cancers (Basel). 2019. PMID: 31703344 Free PMC article.
Does the TT Variant of the rs966423 Polymorphism in DIRC3 Affect the Stage and Clinical Course of Papillary Thyroid Cancer?
Hińcza K, Kowalik A, Pałyga I, Walczyk A, Gąsior-Perczak D, Mikina E, Trybek T, Szymonek M, Gadawska-Juszczyk K, Zajkowska K, Suligowska A, Kuchareczko A, Krawczyk K, Kopczyński J, Chrapek M, Góźdź S, Kowalska A. Hińcza K, et al. Cancers (Basel). 2020 Feb 12;12(2):423. doi: 10.3390/cancers12020423. Cancers (Basel). 2020. PMID: 32059462 Free PMC article.
Incidence of the CHEK2 Germline Mutation and Its Impact on Clinicopathological Features, Treatment Responses, and Disease Course in Patients with Papillary Thyroid Carcinoma.
Gąsior-Perczak D, Kowalik A, Gruszczyński K, Walczyk A, Siołek M, Pałyga I, Trepka S, Mikina E, Trybek T, Kopczyński J, Suligowska A, Ślusarczyk R, Gonet A, Jaskulski J, Orłowski P, Chrapek M, Góźdź S, Kowalska A. Gąsior-Perczak D, et al. Cancers (Basel). 2021 Jan 26;13(3):470. doi: 10.3390/cancers13030470. Cancers (Basel). 2021. PMID: 33530461 Free PMC article.
CHEK2 mutations and the risk of papillary thyroid cancer.
Siołek M, Cybulski C, Gąsior-Perczak D, Kowalik A, Kozak-Klonowska B, Kowalska A, Chłopek M, Kluźniak W, Wokołorczyk D, Pałyga I, Walczyk A, Lizis-Kolus K, Sun P, Lubiński J, Narod SA, Góźdż S. Siołek M, et al. Int J Cancer. 2015 Aug 1;137(3):548-52. doi: 10.1002/ijc.29426. Epub 2015 Jan 28. Int J Cancer. 2015. PMID: 25583358 Free article.
Evaluation of molecular diagnostic approaches for the detection of BRAF p.V600E mutations in papillary thyroid cancer: Clinical implications.
Kowalik A, Kowalska A, Walczyk A, Chodurska R, Kopczyński J, Chrapek M, Wypiórkiewicz E, Chłopek M, Pięciak L, Gąsior-Perczak D, Pałyga I, Gruszczyński K, Nowak E, Góźdź S. Kowalik A, et al. PLoS One. 2017 Jun 21;12(6):e0179691. doi: 10.1371/journal.pone.0179691. eCollection 2017. PLoS One. 2017. PMID: 28636673 Free PMC article.
Response to therapy of papillary thyroid cancer of known BRAF status.
Kowalska A, Walczyk A, Kowalik A, Pałyga I, Gąsior-Perczak D, Trybek T, Kopczyński J, Kajor M, Mikina E, Szymonek M, Gadawska-Juszczyk K, Szyska-Skrobot D, Lizis-Kolus K, Hurej S, Chrapek M, Chłopek M, Góźdź S. Kowalska A, et al. Clin Endocrinol (Oxf). 2017 Dec;87(6):815-824. doi: 10.1111/cen.13423. Epub 2017 Aug 4. Clin Endocrinol (Oxf). 2017. PMID: 28718951
The impact of BMI on clinical progress, response to treatment, and disease course in patients with differentiated thyroid cancer.
Gąsior-Perczak D, Pałyga I, Szymonek M, Kowalik A, Walczyk A, Kopczyński J, Lizis-Kolus K, Trybek T, Mikina E, Szyska-Skrobot D, Gadawska-Juszczyk K, Hurej S, Szczodry A, Słuszniak A, Słuszniak J, Mężyk R, Góźdź S, Kowalska A. Gąsior-Perczak D, et al. PLoS One. 2018 Oct 1;13(10):e0204668. doi: 10.1371/journal.pone.0204668. eCollection 2018. PLoS One. 2018. PMID: 30273371 Free PMC article.
32 results